Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression

Molecular Brain Research

Volumn 37, Issue 1-2, 1996, Pages 209-216

  Nisenbaum, Laura K ^a,b   Crowley, William R ^a   Kitai, S T ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

6 hydroxydopamine; Dopamine; Enkephalin; Messenger RNA; Partial lesion; Striatum; Substance P; Tyrosine hydroxylase

Indexed keywords

ENKEPHALIN; MESSENGER RNA; OXIDOPAMINE; SUBSTANCE P;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; GENE EXPRESSION; HISTOCHEMISTRY; HORMONE DEFICIENCY; HYBRIDIZATION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA;

ANIMALIA;

EID: 0029871852     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-328X(95)00317-L     Document Type: Article

References (40)

1. Abercrombie, E.D., Bonatz, A.E. and Zigmond, M.J., Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res., 525 (1990) 36-44.
2. Agid, Y., Javoy, F. and Glowinski, J., Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat, Nature New Biol., 245 (1973) 150-151.
3. Beckstead, R.M. and Kersey, K.S., Immunohistochemical demonstration of differential substance P-, Met-enkephalin-, and glutamic-acid decarboxylase-containing cell body and axon distributions in the corpus striatum of the cat, J. Comp. Neurol., 232 (1985) 481-498.
4. Browne, R.G. and Segal, D.S., Metabolic and experimental factors in the behavioral response to repeated amphetamine, Pharmacol. Biochem. Behav., 6 (1977) 545-552.
5. Castaneda, E., Whishaw, I.Q. and Robinson, T.E., Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: Variation as a function of lesion size, J. Neurosci., 10 (1990) 1847-1854.
6. Cenci, M.A., Campbell, K. and Bjorklund, A., Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: Differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels, Neuroscience, 57 (1993) 275-296.
7. Dearry, A., Gingrich, J.A., Falardeau, P., Fremeau, R.T., Jr., Bates, M.D. and Caron, M.G., Molecular cloning and expression of the gene for a human D1 dopamine receptor, Nature, 347 (1990) 72-76.
8. Gerfen, C.R., Engber, T.M., Mahan, L.C., Susel, Z., Chase, T.N., Monsma, F.J., Jr. and Sibley, D.R., D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons, Science, 250 (1990) 1429-1432.
9. Gerfen, C.R., McGinty, J.F. and Young, W.S., III, Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons: In situ hybridization histochemical analysis, J. Neurosci., 11 (1991) 1016-1031.
10. Gerfen, C.R. and Young, W.S., III, Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: An in situ hybridization histochemistry and fluorescent retrograde tracing study, Brain Res., 460 (1988) 161-167.
11. Grima, B., Lamouroux, A., Blanot, F., Biguet, N.F. and Mallet, J., Complete coding sequence of rat tyrosine hydroxylase mRNA, Proc. Natl. Acad. Sci. USA, 82 (1985) 617-621.
12. Hefti, F., Melamed, E. and Wurtman, R.J., Partial lesions of the dopaminergic nigrostriatal system in rat brain: Biochemical characterization, Brain Res., 195 (1980) 123-137.
13. Li, S.J., Jiang, H.K., Stachowiak, M.S., Hudson, P.M., Owyang, V., Nanry, K., Tilson, H.A. and Hong, J.S., Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum, Mol. Brain Res., 8 (1990) 219-225.
14. Lowry, O.H., Rosebrough, M., Farr, A. and Randall, R., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
15. Marshall, J.F., Richardson, J.S. and Teitelbaum, P., Nigrostriatal bundle damage and the lateral hypothalamic syndrome, J. Comp. Physiol. Psychol., 87 (1974) 808-830.
16. Nisenbaum, L.K., Kitai, S.T., Crowley, W.R. and Gerfen, C.R., Temporal dissociation between changes in striatal enkephalin and substance P mRNAs following striatal dopamine depletion, Neuroscience, 60 (1994) 927-937.
17. Normand, E., Popovici, T., Onteniente, B., Fellmann, D., Piatier-Tonneau, D., Auffray, C. and Bloch, B., Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons, Brain Res., 439 (1988) 39-46.
18. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
19. 3H]-dopamine release. Pharmacol. Biochem. Behav., 27 (1987) 533-535.
20. Peuler, J.D. and Johnson, G.A., Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine, Life Sci., 21 (1977) 621-636.
21. Reimer, S., Sirinathsinghji, D.J.S., Nikolorakis, K.E. and Hollt, V., Differential dopaminergic regulation of proenkephalin and prodynorphin mRNAs in the basal ganglia of rats, Mol. Brain Res., 12 (1992) 259-266.
22. Robinson, T.E. and Becker, J.B., Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis, Brain Res. Rev., 11 (1986) 157-198.
23. Robinson, T.E., Mocsary, Z., Camp, D.M. and Whishaw, I.Q., Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system, J. Neurosci., 14 (1994) 2687-2696.
24. Robinson, T.E. and Wishaw, I.Q., Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: A microdialysis study in freely moving rats, Brain Res., 450 (1988) 209-224.
25. Seeman, P., Watanabe, M., Grigoriadis, D., Tedesco, J.L., George, S.R., Svensson, U., Nilsson, J.L.G. and Neumeyer, J.L., Dopamine D2 receptor binding sites for agonists: A tetrahedral model, Mol. Pharmacol., 28 (1985) 391-399.
26. Snyder, G.L., Keller, R.W., Jr. and Zigmond, M.J., Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: Evidence for compensatory hyperactivity of residual terminals, J. Pharmacol. Exp. Ther., 253 (1990) 867-876.
27. Sole, M.S. and Hassain, M.N., A simple, specific radioenzymatic assay for the simultaneous measurement of picogram quantities of norepinephrine, epinephrine and dopamine in plasma and tissues, Blochem. Med., 18 (1977) 301-307.
28. Stoof, J.C., Localization and pharmacology of some dopamine receptor complexes in the striatum and the pituitary gland: Synaptic and son-synaptic communication, Acta Morphol. Neerl.-Scand., 26 (1989) 115-130.
29. Ungerstedt, U., 6-hydroxy-dopamine induced degeneration of central monoamine neurons, Eur. J. Pharmacol., 5 (1968) 107-110.
30. Ungerstedt, U., Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system, Acta Physiol. Scand., 367 (Suppl.) (1971) 95-122.
31. Vernier, P., Julien, J.F., Rataboul, P., Fourrier, O., Feurerstein, C. and Mallet, J., Similar time course changes in striatal levels of glutamic acid decarboxylase and proenkephalin mRNA following dopaminergic deafferentation in the rat, J. Neurochem., 51 (1988) 1375-1380.
32. Yoshikawa, K., Williams, C. and Sabol, S.L., Rat brain preproenkephalin mRNA: cDNA cloning, primary structure and distribution in the central nervous system, J. Biol. Chem., 259 (1984) 14301-14308.
33. Young, W.S., III, Bonner, T.I. and Brann, M.R., Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain, Proc. Natl. Acad. Sci. USA, 83 (1986) 9827-9831.
34. Zhang, W.Q., Tilson, H.A., Nanry, K.P., Hudson, P.M., Hong, J.S. and Stachowiak, M.K., Increased dopamine release from striata of rats after unilateral nigrostriatal bundle damage, Brain Res., 461 (1988) 335-342.
35. Zigmond, M.J., Abercrombie, E.D., Berger, T.W., Grace, A.A. and Stricker, E.M., Compensations after lesions of central dopaminergic neruons: Some clinical and basic implications, Trends Neurosci., 13 (1990) 290-296.
36. Zigmond, M.J., Acheson, A.L., Stachowiak, M.K. and Stricker, E.M., Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical Parkinsonism, Arch. Neurol., 41 (1984) 856-861.
37. Zigmond, M.J. and Stricker, E.M., Animal models of Parkinsonism using selective neurotoxins: Clinical and basic implications. Int. Rev. Neurobiol., 31 (1989) 1-79.
38. Zigmond, M.J. and Stricker, E.M., Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science, 177 (1972) 1211-1214.
39. Zigmond, M.J. and Stricker, E.M., Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic syndrome, Science, 182 (1973) 717-720.
40. Zigmond, M.J. and Stricker, E.M., Supersensitivity after intraventricular 6-hydroxydopamine: Relation to dopamine depletion, Experientia, 36 (1980) 436-438.